Recap: Aridis Pharmaceuticals Q1 Earnings
Aridis Pharmaceuticals (NASDAQ:ARDS) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Aridis Pharma COVID-19 Antibody Neutralizes Omicron Variant In Animal Study
Aridis Pharmaceuticals Inc's (NASDAQ: ARDS) fully human monoclonal antibodies (mAbs) in the
Aridis Pharmaceuticals Announces Both Of Its Fully Human Monoclonal Antibodies In AR-701 Cocktail Neutralized SARS-CoV-2 Omicron Variant
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, announced today that both of its
5 Short Squeeze Candidate To Watch: Aridis Pharmaceuticals Tops List, EVgo, Indonesia Energy Corp And More
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Quidel (NASDAQ:QDEL) shares increased by 7.4% to $106.2 during Friday's after-market session. The market value of their outstanding shares is at $4.4 billion.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Cidara Therapeutics (NASDAQ:CDTX) stock moved upwards by 14.1% to $0.91 during Thursday's after-market session. The company's market cap stands at $60.6 million.